Insights

On the Horizon for Hemp: Pending State Regulatory Revisions and Open Comment Periods

By Casey Leaver
May 13, 2024

In the wake of changing laws and mandates for state agencies to regulate certain components of hemp licensing and production, there are a few states on the move with rules and regulations available for review or anticipated shortly. Read this insight about Kentucky’s new emergency rules, Rhode Island’s proposed definition of “consumable,” locality control over smokable hemp sales in Virginia, and more.

Raising Capital for Maryland Social Equity Cannabis Businesses

By Charles Alovisetti, Elena Markos
May 7, 2024

Maryland recently awarded cannabis business licenses to social equity applicants. If you were one of the lucky lottery winners, now it’s time to focus on raising money for your business. Read this insight for essential considerations around raising capital for Maryland social equity cannabis licensees.

4 Major Implications of Cannabis Moving to Schedule III

By Andrew Livingston, Jason Adelstone, Shawn Hauser
Apr 30, 2024

After 50 years of being in the most restrictive schedule alongside drugs like heroin and PCP, the DEA will move to reschedule marijuana from Schedule I to Schedule III, where the plant’s medical benefits will finally be recognized by the federal government. Read this article for answers to four of the most important questions about the effects Schedule III will have on cannabis and society.

Colorado Natural Medicine Advisory Bulletin #11: March & April 2024

By Vicente LLP, Psychedelic Alpha
Apr 30, 2024

Colorado Natural Medicine Advisory Bulletins provide updates on the implementation of Colorado's legal psychedelics program, the Natural Medicine Health Act. Bulletin #11 features summaries of the draft rules covering licensing and financial interests and general/operational rules, the stakeholder meeting feedback on those rules, and notes from the combined subcommittee meeting on April 12 and the full Natural Medicine Advisory Board meeting on April 19.